By Alexander Bueso
Date: Sunday 17 Apr 2022
(Sharecast News) - The Financial Mail on Sunday's Midas column recommended shares of Impact Healthcare, as 'a long-term buy', touting the company's long-term growth prospects, dividend yield of over 5.0% and management's attention to detail which they surmised was paying off.
Impact owned 129 homes catering to more than 5,000 elderly...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news